# Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage

Study · id `cardio:ct-nct07338175` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07338175](<https://clinicaltrials.gov/study/NCT07338175>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07338175

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1192 participants.

## Technical summary

Registry record NCT07338175. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1192 participants (planned count; ClinicalTrials.gov record NCT07338175, source copy `cardio:ctgov-nct07338175-2026-04-23`, retrieved 2026-10-31)
- Started: 2026-04-02 (actual) (ClinicalTrials.gov record NCT07338175, source copy `cardio:ctgov-nct07338175-2026-04-23`, retrieved 2026-10-31)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT07338175, source copy `cardio:ctgov-nct07338175-2026-04-23`, retrieved 2026-10-31)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07338175, source copy `cardio:ctgov-nct07338175-2026-04-23`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT07338175, source copy `cardio:ctgov-nct07338175-2026-04-23`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07338175-2026-04-23`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
- Acronym: MISTICH
- Condition: Intracerebral Hemorrhage
- Intervention (Drug): Minocycline hydrochloride capsules
- Intervention (Drug): Placebo capsules of Minocycline hydrochloride capsules
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: 0df560fc0fe27ac415f5e6260b69ce6b38a7de5464ba909545accde9885ef930
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
